TRENTIN, LIVIO
 Distribuzione geografica
Continente #
NA - Nord America 23.625
EU - Europa 3.655
AS - Asia 1.577
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 6
AF - Africa 3
Totale 28.893
Nazione #
US - Stati Uniti d'America 23.588
CN - Cina 1.370
IT - Italia 1.016
DE - Germania 701
FI - Finlandia 638
SE - Svezia 416
UA - Ucraina 319
GB - Regno Unito 271
RU - Federazione Russa 116
IN - India 85
VN - Vietnam 67
IE - Irlanda 60
FR - Francia 40
CA - Canada 35
NL - Olanda 30
JP - Giappone 16
AU - Australia 14
TR - Turchia 13
ES - Italia 11
EU - Europa 9
RO - Romania 8
IL - Israele 7
PH - Filippine 6
SI - Slovenia 4
AT - Austria 3
BE - Belgio 3
DK - Danimarca 3
GR - Grecia 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
TW - Taiwan 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
MX - Messico 2
PL - Polonia 2
PT - Portogallo 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
HK - Hong Kong 1
HU - Ungheria 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
PY - Paraguay 1
SG - Singapore 1
Totale 28.893
Città #
Fairfield 3.945
Woodbridge 2.364
Chandler 2.019
Ann Arbor 1.903
Houston 1.816
Ashburn 1.623
Wilmington 1.444
Cambridge 1.414
Seattle 1.352
Jacksonville 1.341
Princeton 631
San Diego 436
Beijing 397
Medford 336
Padova 312
Helsinki 280
Nanjing 258
Des Moines 254
Boardman 194
Roxbury 170
New York 120
Shenyang 93
Hebei 72
Dong Ket 65
Nanchang 62
London 57
Changsha 55
Jinan 55
Dublin 54
Jiaxing 53
Norwalk 49
Milan 45
Redwood City 44
Tianjin 40
Guangzhou 37
Pune 37
Falls Church 26
Rome 25
Washington 22
Verona 21
Kilburn 20
Kharkiv 19
Hefei 18
Bologna 16
Hangzhou 16
Malo 16
Ningbo 16
Amsterdam 15
Chicago 15
Zhengzhou 15
Taizhou 14
Haikou 13
Lappeenranta 13
Phoenix 13
Paris 12
Vicenza 12
Ottawa 11
Redmond 11
Yenibosna 11
Borås 10
Fuzhou 10
Hounslow 10
Indiana 10
Nürnberg 10
Taiyuan 10
Regensburg 9
Rockville 8
Storm Lake 8
Melbourne 7
Orange 7
Tokyo 7
Treviso 7
Aprilia 6
Cassano D'adda 6
Hanover 6
Kunming 6
Lanzhou 6
Madrid 6
San Francisco 6
Shanghai 6
Shibuya 6
Tappahannock 6
Venezia 6
Venice 6
Baotou 5
Chieti 5
Chiswick 5
Isola della Scala 5
Las Vegas 5
Mountain View 5
Selvazzano Dentro 5
Trieste 5
Vittorio Veneto 5
Wandsworth 5
Acton 4
Bolzano 4
Edinburgh 4
Pignone 4
San Giovanni Lupatoto 4
Wuhan 4
Totale 24.056
Nome #
R-Vemp Is a Safe and Effective Chemo-Immunotherapeutic Regimen In Elderly Unfit DLBCL Patients: Report From a Single Center-Experience 380
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 187
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL 181
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma 165
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells 159
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 159
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 143
Role of miR-15a/miR-16-1 and TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia 142
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 141
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 141
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 137
Rituximab-responsive CIDP 135
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 135
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia 135
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 131
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 129
Selection of T lymphocyte bearing limited TCR-V beta regions in the lung of hypersensitivity pneumonitis and sarcoidosis. 127
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 127
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. 126
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 126
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 125
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 125
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia 124
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 123
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations and clinical impact 123
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 122
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 121
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A. 120
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia 120
Towards a new age in the treatment of multiple myeloma 119
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 119
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 119
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 118
Early effects of the antineoplastic agent salinomycin on mitochondrial function 118
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 116
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 112
Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic activity: an enzymatic mechanism for influx of mononuclear phagocytes at site of disease activity 111
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 111
Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus 110
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 110
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 109
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 108
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment 108
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 107
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 106
Immunologic abnormalities in angioimmunoblastic lymphadenopathy. 105
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 105
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia 105
CXCR3/CXCL10 interactions in the development of hypersensitivity pneumonitis 105
Ibrutinib Therapy Releases Leukemic Surface IgM from Antigen Drive in Chronic Lymphocytic Leukemia Patients 105
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 105
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes 104
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations 104
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis 104
Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-MAG antibody polyneuropathy 104
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 102
Role of hematopoietic-specific protein 1 (HS1) in apoptosis in B-chronic lymphocytic leukemia. 101
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 101
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. 101
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 101
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission. 101
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine 100
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 100
Extracorporeal photochemotherapy may improve outcome in children with acute GVHD. 99
Antiapoptotic effects of IL-15 on pulmonary Tc1 cells of patients with human immunodeficiency virus infection 99
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 99
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 99
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 99
Role for CXCR6 and its ligand CXCL16 in the pathogenesis of T-cell alveolitis in sarcoidosis 98
CD8+ T lymphocytes in the lung of AIDS patients harbor Human Immunodeficiency Virus Type 1. 97
Childhood onset cyclic neutropenia: G-CSF therapy restores neutrophil count but does not influence superoxide anion and cytokine release by neutrophils. 97
CX-4945, a selective inhibitor of casein kinase 2, synergizes with B cell receptor signaling inhibitors in inducing diffuse large B cell lymphoma cell death 97
Role of protein kinase CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells. 96
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C 96
Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation 96
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 96
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 96
CD40 activation of B-CLL cells is associated with augmented intracellular levels of CD79b and increased BCR expression in a subset of patients 95
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia 95
Phenotypical and functional analysis of natural killer cells in sarcoidosis. 94
Cytotoxic Lymphocytes in the Lungs of Patients with Hypersensitivity Pneumonitis 94
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis 94
Immunoglobulin heavy variable (IGHV) genes and alleles: new entities, new names and implications for research and prognostication in chronic lymphocytic leukaemia. 93
Effects of CK2 inhibition on multiple signaling pathways in myeloma cells. 93
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways 93
Derivati dello psoralene come agenti anti-tumorali selettivi 93
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. 92
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 92
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy 92
Role of GSK3 in multiple myeloma cell growth and survival 91
Cellular immunity in sarcoidosis and hypersensitivity pneumonitis: Recent advances. 91
Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders 91
Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia 91
Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells 90
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 90
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial 90
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape 90
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 90
Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL) 89
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes 89
Totale 11.339
Categoria #
all - tutte 99.851
article - articoli 91.121
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 204
selected - selezionate 0
volume - volumi 1.628
Totale 192.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.150 0 0 0 0 0 0 0 224 54 381 787 704
2019/20205.901 820 198 60 394 561 469 495 687 580 826 466 345
2020/20215.089 324 406 269 437 115 275 345 472 712 763 556 415
2021/20225.702 174 682 646 468 271 263 267 615 343 128 582 1.263
2022/20234.472 953 401 90 565 688 549 50 313 477 54 240 92
2023/20241.652 111 297 247 191 218 318 160 110 0 0 0 0
Totale 29.366